Table 4.
Experimental group N = 8 | Control group N = 88 | |
---|---|---|
Cardiovascular | 1 (12.5%) | 20 (18.1%) |
Pulmonary | 2 (25%) | 12 (10.9%) |
Gastrointestinal | 3 (37.5%) | 31 (28.2%) |
Sepsis/SIRS | 2 (25%) | 9 (8.1%) |
Mental | 1 (12.5%) | 12 (10.9%) |
Wound | 2 (25%) | 7 (6.4%) |
Anastomotic leakage | 0 (0%) | 8 (7.2%) |
Neurological | 1 (12.5%) | 2 (1.8%) |
Nephrological | 0 (0%) | 19 (17.3%) |
CRS cytoreductive surgery, HPEC hyperthermic intraperitoneal chemotherapy